Marian Rewers
Concepts (901)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 1 | 360 | 2023 | 3252 | 21.340 |
Why?
| Islets of Langerhans | 111 | 2023 | 726 | 11.590 |
Why?
| Autoimmunity | 122 | 2023 | 813 | 10.890 |
Why?
| Autoantibodies | 170 | 2023 | 1346 | 10.660 |
Why?
| Celiac Disease | 50 | 2023 | 264 | 7.190 |
Why?
| Genetic Predisposition to Disease | 87 | 2023 | 2085 | 4.140 |
Why?
| Coronary Artery Disease | 34 | 2018 | 607 | 3.730 |
Why?
| Diabetic Angiopathies | 28 | 2017 | 244 | 3.350 |
Why?
| Child, Preschool | 185 | 2023 | 9111 | 3.090 |
Why?
| Calcinosis | 23 | 2015 | 242 | 2.950 |
Why?
| HLA-DQ Antigens | 36 | 2020 | 174 | 2.950 |
Why?
| Insulin Resistance | 55 | 2018 | 1072 | 2.890 |
Why?
| HLA-DR Antigens | 27 | 2021 | 219 | 2.880 |
Why?
| Child | 212 | 2023 | 18407 | 2.770 |
Why?
| Insulin | 73 | 2023 | 2078 | 2.720 |
Why?
| Infant | 157 | 2023 | 7959 | 2.590 |
Why?
| Disease Progression | 76 | 2023 | 2380 | 2.460 |
Why?
| Blood Glucose | 38 | 2022 | 1826 | 2.410 |
Why?
| Risk Factors | 155 | 2023 | 8631 | 2.390 |
Why?
| Humans | 473 | 2023 | 114654 | 2.280 |
Why?
| Genotype | 62 | 2023 | 1760 | 2.130 |
Why?
| Transglutaminases | 28 | 2023 | 142 | 2.130 |
Why?
| Male | 318 | 2022 | 55579 | 2.120 |
Why?
| Prospective Studies | 95 | 2023 | 6217 | 2.110 |
Why?
| Female | 325 | 2022 | 59488 | 2.050 |
Why?
| Biomarkers | 46 | 2023 | 3408 | 1.950 |
Why?
| Diabetic Nephropathies | 19 | 2020 | 234 | 1.820 |
Why?
| Adolescent | 125 | 2023 | 17837 | 1.780 |
Why?
| Polymorphism, Single Nucleotide | 34 | 2021 | 1879 | 1.740 |
Why?
| Insulin Antibodies | 22 | 2023 | 102 | 1.720 |
Why?
| Insulin-Secreting Cells | 15 | 2023 | 317 | 1.690 |
Why?
| Diabetic Ketoacidosis | 11 | 2023 | 159 | 1.690 |
Why?
| Coronary Disease | 15 | 2010 | 348 | 1.580 |
Why?
| Prediabetic State | 14 | 2023 | 219 | 1.560 |
Why?
| Glutamate Decarboxylase | 34 | 2023 | 160 | 1.550 |
Why?
| Autoimmune Diseases | 16 | 2019 | 382 | 1.500 |
Why?
| Diet | 28 | 2021 | 1080 | 1.490 |
Why?
| Case-Control Studies | 56 | 2023 | 3003 | 1.450 |
Why?
| Hyperglycemia | 9 | 2015 | 291 | 1.430 |
Why?
| Follow-Up Studies | 60 | 2021 | 4411 | 1.300 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 10 | 2022 | 46 | 1.300 |
Why?
| Glutens | 11 | 2023 | 56 | 1.260 |
Why?
| HLA Antigens | 23 | 2021 | 225 | 1.260 |
Why?
| Cohort Studies | 66 | 2022 | 4895 | 1.250 |
Why?
| Adult | 155 | 2023 | 30542 | 1.230 |
Why?
| Fatty Acids, Omega-3 | 8 | 2020 | 122 | 1.200 |
Why?
| Mass Screening | 20 | 2022 | 1004 | 1.200 |
Why?
| Diabetes Mellitus, Type 2 | 33 | 2022 | 2094 | 1.190 |
Why?
| Enterovirus Infections | 6 | 2023 | 160 | 1.160 |
Why?
| Polymorphism, Genetic | 15 | 2019 | 610 | 1.110 |
Why?
| Environment | 5 | 2018 | 332 | 1.100 |
Why?
| Middle Aged | 135 | 2021 | 26732 | 1.090 |
Why?
| H(+)-K(+)-Exchanging ATPase | 2 | 2017 | 15 | 1.040 |
Why?
| Erythrocyte Membrane | 5 | 2015 | 50 | 1.020 |
Why?
| Infant, Newborn | 61 | 2023 | 5044 | 1.010 |
Why?
| Atherosclerosis | 15 | 2018 | 341 | 1.010 |
Why?
| Incidence | 35 | 2022 | 2312 | 0.940 |
Why?
| Colorado | 41 | 2023 | 4099 | 0.930 |
Why?
| Albuminuria | 12 | 2016 | 164 | 0.910 |
Why?
| Diabetes Complications | 7 | 2019 | 211 | 0.900 |
Why?
| Coronary Vessels | 8 | 2017 | 227 | 0.900 |
Why?
| Enterovirus | 5 | 2019 | 72 | 0.890 |
Why?
| HLA-DR3 Antigen | 16 | 2023 | 79 | 0.870 |
Why?
| Predictive Value of Tests | 25 | 2019 | 1796 | 0.840 |
Why?
| Vascular Calcification | 9 | 2018 | 107 | 0.830 |
Why?
| Proportional Hazards Models | 24 | 2021 | 1075 | 0.830 |
Why?
| Young Adult | 49 | 2023 | 10465 | 0.800 |
Why?
| Age of Onset | 17 | 2021 | 446 | 0.790 |
Why?
| Glucose Tolerance Test | 26 | 2022 | 343 | 0.770 |
Why?
| Longitudinal Studies | 24 | 2021 | 2387 | 0.770 |
Why?
| Breast Feeding | 18 | 2021 | 368 | 0.770 |
Why?
| Blood Glucose Self-Monitoring | 6 | 2022 | 504 | 0.760 |
Why?
| Genetic Testing | 8 | 2019 | 379 | 0.750 |
Why?
| Fatty Acids | 6 | 2021 | 381 | 0.730 |
Why?
| HLA-DR4 Antigen | 16 | 2022 | 76 | 0.720 |
Why?
| Antibodies, Viral | 6 | 2023 | 520 | 0.720 |
Why?
| Calcium | 8 | 2023 | 1108 | 0.710 |
Why?
| Vitamin D | 7 | 2018 | 341 | 0.670 |
Why?
| Cross-Sectional Studies | 35 | 2023 | 4407 | 0.630 |
Why?
| Infant Nutritional Physiological Phenomena | 5 | 2021 | 133 | 0.630 |
Why?
| Zinc Transporter 8 | 7 | 2021 | 86 | 0.630 |
Why?
| Prevalence | 22 | 2023 | 2250 | 0.620 |
Why?
| Autoantigens | 8 | 2021 | 396 | 0.620 |
Why?
| Uric Acid | 6 | 2018 | 148 | 0.610 |
Why?
| Seroconversion | 6 | 2021 | 45 | 0.610 |
Why?
| Haplotypes | 12 | 2019 | 448 | 0.610 |
Why?
| Logistic Models | 24 | 2017 | 1840 | 0.590 |
Why?
| Infant Food | 7 | 2018 | 63 | 0.580 |
Why?
| Metabolomics | 5 | 2021 | 521 | 0.570 |
Why?
| Adiponectin | 5 | 2016 | 213 | 0.570 |
Why?
| Glomerular Filtration Rate | 15 | 2020 | 604 | 0.570 |
Why?
| Fibrinogen | 5 | 2019 | 154 | 0.560 |
Why?
| Fatty Acids, Unsaturated | 2 | 2016 | 84 | 0.560 |
Why?
| Edible Grain | 4 | 2008 | 43 | 0.550 |
Why?
| Health Care Costs | 1 | 2020 | 381 | 0.550 |
Why?
| Lipids | 5 | 2019 | 580 | 0.550 |
Why?
| GTP-Binding Proteins | 6 | 2021 | 139 | 0.540 |
Why?
| Monitoring, Physiologic | 2 | 2009 | 249 | 0.540 |
Why?
| Inflammation | 8 | 2017 | 2478 | 0.540 |
Why?
| Germany | 11 | 2022 | 84 | 0.530 |
Why?
| Adaptor Proteins, Signal Transducing | 3 | 2013 | 367 | 0.530 |
Why?
| Arteriosclerosis | 17 | 2004 | 83 | 0.530 |
Why?
| Hypoglycemia | 5 | 2014 | 386 | 0.530 |
Why?
| Sensitivity and Specificity | 21 | 2022 | 1691 | 0.530 |
Why?
| Hypertension | 11 | 2021 | 1056 | 0.520 |
Why?
| Age Factors | 37 | 2022 | 2894 | 0.510 |
Why?
| Triglycerides | 13 | 2020 | 467 | 0.500 |
Why?
| Body Mass Index | 22 | 2023 | 1958 | 0.500 |
Why?
| Prenatal Exposure Delayed Effects | 6 | 2021 | 452 | 0.490 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 11 | 2021 | 58 | 0.490 |
Why?
| Milk | 7 | 2017 | 124 | 0.480 |
Why?
| Luminescent Measurements | 4 | 2021 | 74 | 0.480 |
Why?
| C-Reactive Protein | 5 | 2018 | 362 | 0.480 |
Why?
| Probiotics | 3 | 2022 | 46 | 0.480 |
Why?
| C-Peptide | 5 | 2021 | 138 | 0.480 |
Why?
| Time Factors | 21 | 2018 | 6115 | 0.470 |
Why?
| Helicobacter Infections | 1 | 2014 | 25 | 0.470 |
Why?
| Helicobacter pylori | 1 | 2014 | 30 | 0.470 |
Why?
| Risk | 17 | 2020 | 812 | 0.460 |
Why?
| Asymptomatic Diseases | 3 | 2023 | 75 | 0.450 |
Why?
| Prognosis | 17 | 2021 | 3327 | 0.440 |
Why?
| Fatty Acids, Monounsaturated | 2 | 2014 | 47 | 0.440 |
Why?
| Risk Assessment | 17 | 2021 | 2968 | 0.440 |
Why?
| Alleles | 14 | 2021 | 789 | 0.440 |
Why?
| Fatty Acid Desaturases | 1 | 2013 | 29 | 0.440 |
Why?
| Dyslipidemias | 4 | 2015 | 154 | 0.440 |
Why?
| Immunogenetics | 1 | 2013 | 6 | 0.430 |
Why?
| Finland | 14 | 2022 | 69 | 0.430 |
Why?
| Glucose Clamp Technique | 8 | 2020 | 181 | 0.420 |
Why?
| Smoking | 8 | 2019 | 1381 | 0.420 |
Why?
| Dietary Supplements | 6 | 2019 | 460 | 0.420 |
Why?
| Genome-Wide Association Study | 7 | 2021 | 1177 | 0.420 |
Why?
| Hypoglycemic Agents | 8 | 2020 | 1012 | 0.410 |
Why?
| Oxylipins | 3 | 2023 | 27 | 0.410 |
Why?
| Fasting | 12 | 2015 | 240 | 0.410 |
Why?
| HLA-D Antigens | 5 | 2019 | 34 | 0.410 |
Why?
| Dietary Fats | 3 | 2014 | 287 | 0.410 |
Why?
| Ascorbic Acid | 4 | 2023 | 110 | 0.410 |
Why?
| Antibodies | 4 | 2014 | 371 | 0.400 |
Why?
| Child Nutritional Physiological Phenomena | 4 | 2019 | 97 | 0.400 |
Why?
| DNA Methylation | 3 | 2021 | 495 | 0.400 |
Why?
| Liver | 3 | 2012 | 1637 | 0.400 |
Why?
| Vitamin D Deficiency | 2 | 2011 | 158 | 0.400 |
Why?
| Lipoproteins | 4 | 2015 | 159 | 0.400 |
Why?
| Early Diagnosis | 6 | 2020 | 217 | 0.390 |
Why?
| Sweden | 12 | 2021 | 65 | 0.390 |
Why?
| Apolipoproteins A | 2 | 2006 | 18 | 0.390 |
Why?
| Sex Factors | 20 | 2020 | 1715 | 0.390 |
Why?
| Fetal Blood | 6 | 2021 | 270 | 0.380 |
Why?
| Adipocytes | 1 | 2012 | 188 | 0.370 |
Why?
| Life Style | 5 | 2015 | 430 | 0.370 |
Why?
| Precision Medicine | 1 | 2014 | 337 | 0.370 |
Why?
| United States | 33 | 2022 | 12179 | 0.370 |
Why?
| Dietary Proteins | 4 | 2019 | 122 | 0.360 |
Why?
| Hypolipidemic Agents | 2 | 2010 | 86 | 0.360 |
Why?
| Obesity | 12 | 2015 | 2508 | 0.360 |
Why?
| Cholesterol, HDL | 8 | 2015 | 183 | 0.350 |
Why?
| Plant Proteins | 1 | 2011 | 81 | 0.350 |
Why?
| Epidemics | 1 | 2011 | 69 | 0.350 |
Why?
| Surveys and Questionnaires | 16 | 2020 | 4622 | 0.350 |
Why?
| Evidence-Based Medicine | 1 | 2014 | 668 | 0.350 |
Why?
| Patient Education as Topic | 2 | 2005 | 680 | 0.350 |
Why?
| Eating | 5 | 2023 | 344 | 0.350 |
Why?
| Research | 2 | 2013 | 394 | 0.350 |
Why?
| CTLA-4 Antigen | 5 | 2017 | 76 | 0.340 |
Why?
| Blood Proteins | 3 | 2017 | 231 | 0.340 |
Why?
| Clinical Trials as Topic | 3 | 2009 | 931 | 0.340 |
Why?
| Steroid 21-Hydroxylase | 5 | 2012 | 30 | 0.330 |
Why?
| Cystatin C | 6 | 2014 | 62 | 0.330 |
Why?
| Addison Disease | 5 | 2012 | 40 | 0.330 |
Why?
| Multivariate Analysis | 10 | 2016 | 1430 | 0.320 |
Why?
| Antigens, CD | 2 | 2009 | 442 | 0.320 |
Why?
| Family Health | 8 | 2017 | 193 | 0.320 |
Why?
| HLA-DQ beta-Chains | 11 | 2019 | 57 | 0.320 |
Why?
| Diet, Ketogenic | 1 | 2009 | 33 | 0.320 |
Why?
| Diabetes Mellitus | 8 | 2009 | 900 | 0.320 |
Why?
| Tomography, X-Ray Computed | 12 | 2018 | 2285 | 0.310 |
Why?
| Rotavirus | 2 | 2016 | 22 | 0.310 |
Why?
| Sex Distribution | 5 | 2011 | 337 | 0.300 |
Why?
| Exercise | 4 | 2023 | 1644 | 0.300 |
Why?
| Reproductive History | 1 | 2008 | 12 | 0.300 |
Why?
| Europe | 11 | 2021 | 334 | 0.300 |
Why?
| Adiposity | 7 | 2020 | 457 | 0.300 |
Why?
| Iron | 3 | 2023 | 233 | 0.300 |
Why?
| Angiotensin II Type 2 Receptor Blockers | 1 | 2007 | 7 | 0.290 |
Why?
| Adipose Tissue | 4 | 2018 | 539 | 0.290 |
Why?
| Cystatins | 1 | 2007 | 7 | 0.290 |
Why?
| Reference Values | 10 | 2012 | 743 | 0.290 |
Why?
| Seroepidemiologic Studies | 4 | 2023 | 138 | 0.290 |
Why?
| Respiratory Tract Infections | 4 | 2017 | 319 | 0.290 |
Why?
| Proteomics | 5 | 2021 | 836 | 0.290 |
Why?
| Aged | 44 | 2021 | 19068 | 0.290 |
Why?
| Metabolome | 2 | 2020 | 282 | 0.280 |
Why?
| Overweight | 3 | 2021 | 471 | 0.280 |
Why?
| RNA, Viral | 3 | 2019 | 565 | 0.280 |
Why?
| Survival Analysis | 4 | 2021 | 1211 | 0.280 |
Why?
| Patient Compliance | 3 | 2023 | 525 | 0.280 |
Why?
| Glycopeptides | 2 | 2018 | 43 | 0.280 |
Why?
| Feces | 6 | 2019 | 373 | 0.270 |
Why?
| Remission Induction | 2 | 2004 | 233 | 0.270 |
Why?
| Renin-Angiotensin System | 1 | 2007 | 72 | 0.270 |
Why?
| Contraception | 1 | 2008 | 117 | 0.270 |
Why?
| Major Histocompatibility Complex | 4 | 2011 | 217 | 0.270 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 179 | 0.270 |
Why?
| Apolipoproteins C | 1 | 2006 | 6 | 0.270 |
Why?
| Rotavirus Infections | 1 | 2006 | 50 | 0.270 |
Why?
| HLA-DRB1 Chains | 7 | 2019 | 98 | 0.270 |
Why?
| Pregnancy | 16 | 2021 | 5517 | 0.260 |
Why?
| Protein Tyrosine Phosphatases | 7 | 2006 | 147 | 0.260 |
Why?
| Regression Analysis | 15 | 2014 | 944 | 0.260 |
Why?
| Infant Formula | 3 | 2019 | 74 | 0.260 |
Why?
| Immunotherapy | 1 | 2009 | 474 | 0.250 |
Why?
| Receptors, Interleukin-2 | 1 | 2005 | 64 | 0.250 |
Why?
| Carotid Arteries | 5 | 1998 | 180 | 0.250 |
Why?
| Cardiovascular Diseases | 7 | 2018 | 1727 | 0.250 |
Why?
| Maternal Age | 3 | 2004 | 117 | 0.250 |
Why?
| Diet Records | 4 | 2019 | 76 | 0.250 |
Why?
| Animals | 26 | 2022 | 31698 | 0.250 |
Why?
| Proinsulin | 3 | 2014 | 48 | 0.250 |
Why?
| Antihypertensive Agents | 2 | 2007 | 429 | 0.250 |
Why?
| Histocompatibility Antigens Class II | 5 | 2011 | 352 | 0.240 |
Why?
| Apolipoproteins | 3 | 2014 | 36 | 0.240 |
Why?
| Glucose Intolerance | 7 | 2013 | 136 | 0.240 |
Why?
| Docosahexaenoic Acids | 3 | 2021 | 69 | 0.240 |
Why?
| Plasminogen Activator Inhibitor 1 | 6 | 2017 | 83 | 0.240 |
Why?
| Abdominal Wall | 1 | 2004 | 24 | 0.240 |
Why?
| Linear Models | 7 | 2016 | 768 | 0.240 |
Why?
| Health Surveys | 3 | 2018 | 443 | 0.240 |
Why?
| Tobacco Smoke Pollution | 4 | 2019 | 217 | 0.240 |
Why?
| Gene Frequency | 9 | 2020 | 477 | 0.240 |
Why?
| Hyperlipidemias | 1 | 2005 | 121 | 0.230 |
Why?
| Diet, Gluten-Free | 2 | 2023 | 30 | 0.230 |
Why?
| Bone Density | 2 | 2020 | 432 | 0.230 |
Why?
| Delivery, Obstetric | 2 | 2004 | 118 | 0.230 |
Why?
| Histocompatibility Antigens Class I | 4 | 2011 | 172 | 0.230 |
Why?
| Muscle, Skeletal | 2 | 2018 | 1472 | 0.230 |
Why?
| Gene-Environment Interaction | 4 | 2021 | 183 | 0.230 |
Why?
| Child Development | 2 | 2020 | 385 | 0.220 |
Why?
| Haptoglobins | 3 | 2013 | 47 | 0.220 |
Why?
| Birth Weight | 4 | 2016 | 440 | 0.220 |
Why?
| Genetic Variation | 3 | 2021 | 870 | 0.220 |
Why?
| Alcohol Drinking | 1 | 2009 | 651 | 0.220 |
Why?
| Electrochemical Techniques | 2 | 2021 | 45 | 0.220 |
Why?
| Alanine Transaminase | 2 | 2015 | 141 | 0.220 |
Why?
| Coronary Angiography | 2 | 2014 | 304 | 0.220 |
Why?
| Iron Overload | 1 | 2023 | 9 | 0.220 |
Why?
| ROC Curve | 4 | 2019 | 442 | 0.210 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 351 | 0.210 |
Why?
| Virus Diseases | 4 | 2021 | 195 | 0.210 |
Why?
| Diabetic Retinopathy | 4 | 2016 | 149 | 0.210 |
Why?
| Mothers | 4 | 2021 | 651 | 0.210 |
Why?
| Pediatrics | 4 | 2020 | 979 | 0.210 |
Why?
| Influenza, Human | 2 | 2022 | 546 | 0.210 |
Why?
| Lipid Metabolism | 2 | 2019 | 444 | 0.210 |
Why?
| Parents | 6 | 2023 | 1186 | 0.210 |
Why?
| Kaplan-Meier Estimate | 4 | 2018 | 811 | 0.210 |
Why?
| Ketone Bodies | 2 | 2014 | 15 | 0.200 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2010 | 373 | 0.200 |
Why?
| Costs and Cost Analysis | 2 | 2020 | 196 | 0.200 |
Why?
| Blood Pressure | 9 | 2014 | 1538 | 0.200 |
Why?
| Gastrointestinal Microbiome | 2 | 2018 | 501 | 0.200 |
Why?
| Maternal Nutritional Physiological Phenomena | 2 | 2021 | 141 | 0.200 |
Why?
| Micronutrients | 2 | 2017 | 78 | 0.200 |
Why?
| Lipase | 1 | 2002 | 55 | 0.200 |
Why?
| Chromosome Mapping | 3 | 2021 | 487 | 0.190 |
Why?
| White Matter | 1 | 2023 | 104 | 0.190 |
Why?
| Promoter Regions, Genetic | 2 | 2006 | 1131 | 0.190 |
Why?
| Odds Ratio | 6 | 2015 | 953 | 0.190 |
Why?
| Gestational Age | 3 | 2020 | 760 | 0.190 |
Why?
| Dietary Approaches To Stop Hypertension | 1 | 2021 | 10 | 0.190 |
Why?
| Mass Spectrometry | 3 | 2021 | 633 | 0.190 |
Why?
| Body Height | 3 | 2014 | 180 | 0.190 |
Why?
| Carnitine O-Palmitoyltransferase | 1 | 2021 | 43 | 0.190 |
Why?
| Glycerol | 2 | 2012 | 84 | 0.190 |
Why?
| Monitoring, Ambulatory | 2 | 2014 | 81 | 0.190 |
Why?
| Receptors, Calcitriol | 2 | 2012 | 53 | 0.190 |
Why?
| Growth | 2 | 2016 | 55 | 0.190 |
Why?
| Polysaccharides | 2 | 2022 | 78 | 0.180 |
Why?
| Genomics | 2 | 2021 | 635 | 0.180 |
Why?
| Reproducibility of Results | 8 | 2021 | 2762 | 0.180 |
Why?
| Age Distribution | 4 | 2011 | 342 | 0.180 |
Why?
| F2-Isoprostanes | 2 | 2015 | 14 | 0.180 |
Why?
| Vitamins | 2 | 2020 | 151 | 0.180 |
Why?
| Gastroenteritis | 2 | 2016 | 65 | 0.180 |
Why?
| Luminescence | 3 | 2016 | 33 | 0.180 |
Why?
| Immunoglobulin A | 5 | 2021 | 166 | 0.180 |
Why?
| Kidney | 2 | 2018 | 1188 | 0.180 |
Why?
| HLA-B8 Antigen | 4 | 2012 | 14 | 0.180 |
Why?
| Influenza Vaccines | 2 | 2017 | 497 | 0.180 |
Why?
| Ketosis | 1 | 2020 | 12 | 0.180 |
Why?
| Developing Countries | 2 | 1993 | 235 | 0.180 |
Why?
| Neonatal Screening | 4 | 2020 | 152 | 0.170 |
Why?
| Oxidative Stress | 3 | 2017 | 1076 | 0.170 |
Why?
| Energy Intake | 5 | 2023 | 427 | 0.170 |
Why?
| Dietary Carbohydrates | 2 | 2015 | 138 | 0.170 |
Why?
| Prodromal Symptoms | 1 | 2020 | 11 | 0.170 |
Why?
| Disease Susceptibility | 6 | 2020 | 316 | 0.170 |
Why?
| Dietary Sucrose | 1 | 2020 | 45 | 0.170 |
Why?
| Sugars | 1 | 2020 | 29 | 0.170 |
Why?
| Biopsy | 5 | 2017 | 1036 | 0.170 |
Why?
| Mannose | 1 | 2019 | 21 | 0.170 |
Why?
| Pregnancy Complications, Infectious | 1 | 2003 | 288 | 0.170 |
Why?
| Life Change Events | 1 | 2021 | 135 | 0.170 |
Why?
| Mice, Inbred NOD | 5 | 2015 | 555 | 0.170 |
Why?
| Quality-Adjusted Life Years | 1 | 2020 | 101 | 0.170 |
Why?
| Interferon-gamma | 2 | 2021 | 719 | 0.170 |
Why?
| Phospholipids | 1 | 2021 | 197 | 0.170 |
Why?
| Adenosine Diphosphate | 1 | 2019 | 81 | 0.170 |
Why?
| Peptides | 2 | 2023 | 848 | 0.170 |
Why?
| Metabolic Clearance Rate | 3 | 2014 | 102 | 0.170 |
Why?
| Epidemiologic Methods | 4 | 2014 | 72 | 0.160 |
Why?
| Enzyme-Linked Immunosorbent Assay | 5 | 2013 | 797 | 0.160 |
Why?
| Measles | 1 | 2019 | 38 | 0.160 |
Why?
| Cation Transport Proteins | 3 | 2011 | 123 | 0.160 |
Why?
| Butyrates | 1 | 2019 | 53 | 0.160 |
Why?
| Apolipoproteins B | 2 | 2015 | 41 | 0.160 |
Why?
| Osteoporotic Fractures | 1 | 2020 | 56 | 0.160 |
Why?
| Glycosuria | 2 | 2009 | 8 | 0.160 |
Why?
| Cholesterol | 5 | 2014 | 367 | 0.160 |
Why?
| Antibodies, Bacterial | 1 | 2019 | 119 | 0.160 |
Why?
| Fatty Acids, Omega-6 | 4 | 2020 | 45 | 0.160 |
Why?
| Uromodulin | 1 | 2018 | 21 | 0.160 |
Why?
| Genetic Markers | 4 | 2013 | 320 | 0.160 |
Why?
| Self Report | 3 | 2020 | 696 | 0.160 |
Why?
| Cotinine | 1 | 2019 | 69 | 0.160 |
Why?
| Models, Biological | 5 | 2019 | 1620 | 0.160 |
Why?
| Mexican Americans | 3 | 2014 | 101 | 0.150 |
Why?
| Health Expenditures | 1 | 2020 | 171 | 0.150 |
Why?
| HLA-DP beta-Chains | 3 | 2015 | 76 | 0.150 |
Why?
| Cost-Benefit Analysis | 2 | 2020 | 544 | 0.150 |
Why?
| High-Throughput Screening Assays | 1 | 2019 | 123 | 0.150 |
Why?
| Sodium Bicarbonate | 1 | 2018 | 40 | 0.150 |
Why?
| Gene Expression Profiling | 5 | 2017 | 1518 | 0.150 |
Why?
| Cost of Illness | 1 | 2020 | 254 | 0.150 |
Why?
| Squalene | 1 | 2017 | 5 | 0.150 |
Why?
| Hypersensitivity | 1 | 2021 | 252 | 0.150 |
Why?
| Environmental Exposure | 2 | 2015 | 372 | 0.150 |
Why?
| HLA-DR2 Antigen | 2 | 2012 | 8 | 0.150 |
Why?
| Feeding Behavior | 3 | 2013 | 574 | 0.150 |
Why?
| Polyendocrinopathies, Autoimmune | 1 | 2017 | 18 | 0.150 |
Why?
| Genes, MHC Class II | 2 | 2012 | 69 | 0.150 |
Why?
| Immune Tolerance | 1 | 2019 | 323 | 0.140 |
Why?
| Kidney Diseases | 2 | 2012 | 350 | 0.140 |
Why?
| Immunologic Memory | 1 | 2019 | 313 | 0.140 |
Why?
| Antipyretics | 1 | 2017 | 4 | 0.140 |
Why?
| Body Composition | 3 | 2020 | 590 | 0.140 |
Why?
| CD4-Positive T-Lymphocytes | 3 | 2021 | 959 | 0.140 |
Why?
| Blood Cell Count | 1 | 2017 | 50 | 0.140 |
Why?
| Radioimmunoassay | 6 | 2016 | 162 | 0.140 |
Why?
| Rheumatoid Factor | 3 | 2007 | 157 | 0.140 |
Why?
| Immunization | 1 | 1999 | 397 | 0.140 |
Why?
| Cytokines | 4 | 2017 | 1840 | 0.140 |
Why?
| Models, Genetic | 2 | 2017 | 562 | 0.140 |
Why?
| Osteoporosis | 1 | 2020 | 226 | 0.140 |
Why?
| Genetic Loci | 3 | 2015 | 262 | 0.140 |
Why?
| Immunoglobulin G | 4 | 2021 | 770 | 0.140 |
Why?
| Epitopes | 4 | 2021 | 435 | 0.140 |
Why?
| Poland | 4 | 2010 | 29 | 0.140 |
Why?
| Renal Insufficiency, Chronic | 3 | 2018 | 486 | 0.140 |
Why?
| Proteins | 2 | 2021 | 908 | 0.140 |
Why?
| Prenatal Nutritional Physiological Phenomena | 1 | 2017 | 57 | 0.140 |
Why?
| Body Weight | 3 | 2016 | 870 | 0.140 |
Why?
| Milk Proteins | 1 | 1996 | 36 | 0.130 |
Why?
| Toxins, Biological | 1 | 2016 | 11 | 0.130 |
Why?
| Homozygote | 5 | 2014 | 187 | 0.130 |
Why?
| Arachidonic Acid | 2 | 2021 | 116 | 0.130 |
Why?
| Models, Theoretical | 2 | 2017 | 515 | 0.130 |
Why?
| Vitamin B 12 | 1 | 2017 | 115 | 0.130 |
Why?
| Cesarean Section | 1 | 2018 | 169 | 0.130 |
Why?
| Hygiene | 1 | 2016 | 27 | 0.130 |
Why?
| Anorexia Nervosa | 1 | 2017 | 64 | 0.130 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 7 | 2006 | 44 | 0.130 |
Why?
| Polymerase Chain Reaction | 5 | 2011 | 993 | 0.130 |
Why?
| Practice Guidelines as Topic | 1 | 2023 | 1394 | 0.130 |
Why?
| Erythrocytes | 1 | 2021 | 591 | 0.130 |
Why?
| HLA-A1 Antigen | 2 | 2006 | 3 | 0.130 |
Why?
| Stress, Psychological | 2 | 2021 | 944 | 0.130 |
Why?
| Diet Surveys | 4 | 2021 | 78 | 0.130 |
Why?
| HLA-DP Antigens | 2 | 2007 | 32 | 0.130 |
Why?
| Oxygen | 1 | 2020 | 854 | 0.130 |
Why?
| High-Throughput Nucleotide Sequencing | 2 | 2022 | 439 | 0.130 |
Why?
| Analgesics, Non-Narcotic | 1 | 2017 | 120 | 0.130 |
Why?
| Lentigo | 1 | 2015 | 5 | 0.130 |
Why?
| Rural Health | 1 | 1996 | 67 | 0.130 |
Why?
| Feeding Methods | 1 | 2015 | 6 | 0.130 |
Why?
| Absorptiometry, Photon | 2 | 2020 | 224 | 0.120 |
Why?
| Oligonucleotide Array Sequence Analysis | 4 | 2011 | 740 | 0.120 |
Why?
| Histocompatibility Testing | 6 | 2017 | 116 | 0.120 |
Why?
| Medical Records | 2 | 2007 | 153 | 0.120 |
Why?
| Dietary Fiber | 1 | 2015 | 40 | 0.120 |
Why?
| Carbohydrates | 1 | 2015 | 55 | 0.120 |
Why?
| Complement C3 | 1 | 2016 | 188 | 0.120 |
Why?
| Genetic Association Studies | 4 | 2020 | 339 | 0.120 |
Why?
| Child Day Care Centers | 1 | 2015 | 33 | 0.120 |
Why?
| Periodontal Diseases | 1 | 2015 | 57 | 0.120 |
Why?
| Up-Regulation | 2 | 2016 | 807 | 0.120 |
Why?
| Phenotype | 7 | 2021 | 2796 | 0.120 |
Why?
| International Agencies | 1 | 2014 | 30 | 0.120 |
Why?
| Gram-Positive Bacteria | 1 | 2014 | 45 | 0.120 |
Why?
| Fructosamine | 1 | 2014 | 14 | 0.120 |
Why?
| Gram-Negative Bacteria | 1 | 2014 | 66 | 0.120 |
Why?
| Dairy Products | 1 | 2014 | 30 | 0.120 |
Why?
| Health Records, Personal | 1 | 2014 | 24 | 0.120 |
Why?
| Carotid Artery Diseases | 3 | 2000 | 57 | 0.120 |
Why?
| Renal Insufficiency | 1 | 2016 | 137 | 0.120 |
Why?
| Acetaminophen | 1 | 2017 | 241 | 0.120 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 299 | 0.120 |
Why?
| Societies, Scientific | 1 | 2014 | 47 | 0.120 |
Why?
| Genetic Linkage | 2 | 2015 | 294 | 0.120 |
Why?
| Mice | 11 | 2022 | 14863 | 0.120 |
Why?
| Adolescent Medicine | 1 | 2014 | 33 | 0.110 |
Why?
| Bias | 1 | 2015 | 179 | 0.110 |
Why?
| Hypoxia | 1 | 2020 | 957 | 0.110 |
Why?
| Molecular Sequence Data | 7 | 2015 | 2785 | 0.110 |
Why?
| Hemodynamics | 1 | 2018 | 1012 | 0.110 |
Why?
| Eicosapentaenoic Acid | 1 | 2013 | 28 | 0.110 |
Why?
| Cholesterol, Dietary | 1 | 2013 | 15 | 0.110 |
Why?
| Creatinine | 4 | 2018 | 425 | 0.110 |
Why?
| Patient Care Planning | 1 | 2014 | 139 | 0.110 |
Why?
| Heart Rate | 3 | 2010 | 709 | 0.110 |
Why?
| Gene Expression | 3 | 2021 | 1421 | 0.110 |
Why?
| Sex Characteristics | 7 | 2015 | 640 | 0.110 |
Why?
| Eggs | 1 | 2013 | 30 | 0.110 |
Why?
| Pilot Projects | 4 | 2023 | 1373 | 0.110 |
Why?
| Communicable Diseases | 1 | 2015 | 129 | 0.110 |
Why?
| Phosphates | 1 | 2014 | 159 | 0.110 |
Why?
| Tumor Suppressor Proteins | 1 | 2015 | 282 | 0.110 |
Why?
| Proteome | 1 | 2016 | 339 | 0.110 |
Why?
| Siblings | 3 | 2018 | 221 | 0.110 |
Why?
| Amino Acid Sequence | 5 | 2015 | 1982 | 0.110 |
Why?
| Receptors, Antigen, T-Cell | 3 | 2023 | 615 | 0.110 |
Why?
| Immunity, Innate | 2 | 2022 | 720 | 0.110 |
Why?
| Biological Specimen Banks | 1 | 2013 | 94 | 0.100 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2012 | 11 | 0.100 |
Why?
| Monoamine Oxidase | 1 | 2012 | 27 | 0.100 |
Why?
| History, 21st Century | 1 | 2013 | 159 | 0.100 |
Why?
| Specimen Handling | 1 | 2013 | 155 | 0.100 |
Why?
| Research Support as Topic | 1 | 2013 | 108 | 0.100 |
Why?
| Iodide Peroxidase | 4 | 2020 | 27 | 0.100 |
Why?
| Chromosomes, Human, Pair 2 | 2 | 2009 | 27 | 0.100 |
Why?
| Organizational Innovation | 1 | 2013 | 132 | 0.100 |
Why?
| Stomach | 1 | 2012 | 102 | 0.100 |
Why?
| Lymphocytes | 1 | 2014 | 330 | 0.100 |
Why?
| History, 20th Century | 1 | 2013 | 264 | 0.100 |
Why?
| Intestine, Small | 2 | 2005 | 122 | 0.100 |
Why?
| Epistasis, Genetic | 1 | 2012 | 67 | 0.100 |
Why?
| Viruses | 1 | 2013 | 94 | 0.100 |
Why?
| Interleukin-4 | 2 | 2005 | 206 | 0.100 |
Why?
| Nuclear Family | 2 | 2009 | 49 | 0.100 |
Why?
| Patient Selection | 3 | 2011 | 641 | 0.100 |
Why?
| Hyperinsulinism | 2 | 2010 | 103 | 0.100 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2016 | 800 | 0.100 |
Why?
| Histocompatibility Antigens | 2 | 2013 | 98 | 0.100 |
Why?
| Pedigree | 4 | 2017 | 460 | 0.100 |
Why?
| Intestines | 1 | 2014 | 326 | 0.100 |
Why?
| Primary Prevention | 1 | 2013 | 172 | 0.100 |
Why?
| Combined Modality Therapy | 1 | 2014 | 1121 | 0.100 |
Why?
| Calcifediol | 1 | 2011 | 29 | 0.100 |
Why?
| Toll-Like Receptors | 1 | 2012 | 167 | 0.090 |
Why?
| Gliadin | 2 | 2009 | 12 | 0.090 |
Why?
| Weight Gain | 2 | 2011 | 453 | 0.090 |
Why?
| Vaccines | 1 | 2016 | 375 | 0.090 |
Why?
| Interleukin-2 | 1 | 2012 | 413 | 0.090 |
Why?
| HLA-B Antigens | 1 | 2011 | 56 | 0.090 |
Why?
| Dose-Response Relationship, Drug | 3 | 2017 | 1842 | 0.090 |
Why?
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2011 | 21 | 0.090 |
Why?
| Video Recording | 1 | 2011 | 143 | 0.090 |
Why?
| Kidney Function Tests | 1 | 2011 | 140 | 0.090 |
Why?
| Milk, Human | 3 | 2018 | 127 | 0.090 |
Why?
| Decision Support Techniques | 2 | 2013 | 355 | 0.090 |
Why?
| Vitamin D-Binding Protein | 1 | 2010 | 13 | 0.090 |
Why?
| Vascular Diseases | 2 | 2013 | 230 | 0.090 |
Why?
| Gastrointestinal Diseases | 1 | 2012 | 182 | 0.090 |
Why?
| Myocardial Infarction | 2 | 1994 | 927 | 0.090 |
Why?
| Endocrine Cells | 1 | 2010 | 6 | 0.090 |
Why?
| Food, Fortified | 1 | 2010 | 36 | 0.090 |
Why?
| Linkage Disequilibrium | 4 | 2015 | 245 | 0.090 |
Why?
| Microbiota | 2 | 2014 | 647 | 0.090 |
Why?
| Family | 5 | 2018 | 589 | 0.090 |
Why?
| Socioeconomic Factors | 5 | 2017 | 1078 | 0.090 |
Why?
| RNA | 1 | 2016 | 809 | 0.090 |
Why?
| Abdomen | 1 | 2010 | 99 | 0.090 |
Why?
| Membrane Proteins | 3 | 2002 | 1018 | 0.090 |
Why?
| Lymphocyte Activation | 1 | 2014 | 1037 | 0.090 |
Why?
| Nutrition Assessment | 2 | 2015 | 75 | 0.090 |
Why?
| Interleukin-1beta | 1 | 2012 | 370 | 0.090 |
Why?
| Leukocytes, Mononuclear | 2 | 2012 | 493 | 0.090 |
Why?
| Transcription Factors | 1 | 2017 | 1528 | 0.080 |
Why?
| Fatty Acids, Nonesterified | 1 | 2010 | 151 | 0.080 |
Why?
| Monitoring, Immunologic | 1 | 2009 | 23 | 0.080 |
Why?
| Metabolic Syndrome | 1 | 2013 | 321 | 0.080 |
Why?
| Pancreas | 2 | 2023 | 276 | 0.080 |
Why?
| Quality Control | 3 | 2013 | 144 | 0.080 |
Why?
| Waist-Hip Ratio | 2 | 2009 | 30 | 0.080 |
Why?
| Homeostasis | 2 | 2010 | 573 | 0.080 |
Why?
| Sequence Analysis, DNA | 3 | 2011 | 723 | 0.080 |
Why?
| Magnetic Resonance Spectroscopy | 3 | 2016 | 473 | 0.080 |
Why?
| Bifidobacterium | 2 | 2018 | 21 | 0.080 |
Why?
| Telomere | 3 | 2022 | 202 | 0.080 |
Why?
| Environmental Monitoring | 1 | 2010 | 254 | 0.080 |
Why?
| Spleen | 1 | 2010 | 487 | 0.080 |
Why?
| Antigens, Viral | 2 | 2021 | 176 | 0.080 |
Why?
| Proteinuria | 1 | 2009 | 77 | 0.080 |
Why?
| Insulin Infusion Systems | 2 | 2017 | 299 | 0.080 |
Why?
| Anti-Bacterial Agents | 1 | 2017 | 1481 | 0.080 |
Why?
| Glycemic Index | 1 | 2008 | 21 | 0.080 |
Why?
| Interleukin-6 | 1 | 2012 | 676 | 0.080 |
Why?
| Isoenzymes | 2 | 2006 | 283 | 0.080 |
Why?
| Disease Outbreaks | 2 | 1991 | 307 | 0.080 |
Why?
| DEAD-box RNA Helicases | 1 | 2008 | 56 | 0.080 |
Why?
| Laboratories | 1 | 2009 | 95 | 0.070 |
Why?
| Tandem Mass Spectrometry | 2 | 2021 | 411 | 0.070 |
Why?
| Pediatric Obesity | 1 | 2014 | 488 | 0.070 |
Why?
| Antibody Formation | 1 | 2008 | 266 | 0.070 |
Why?
| Angiotensins | 1 | 2007 | 10 | 0.070 |
Why?
| Receptor, Angiotensin, Type 1 | 1 | 2007 | 20 | 0.070 |
Why?
| Contraceptive Agents, Female | 1 | 2008 | 64 | 0.070 |
Why?
| Antidepressive Agents | 1 | 2009 | 195 | 0.070 |
Why?
| Lipoproteins, LDL | 2 | 2008 | 128 | 0.070 |
Why?
| Population Surveillance | 3 | 2020 | 392 | 0.070 |
Why?
| Clinical Laboratory Techniques | 1 | 2007 | 87 | 0.070 |
Why?
| Peptidyl-Dipeptidase A | 1 | 2007 | 51 | 0.070 |
Why?
| Epigenesis, Genetic | 2 | 2021 | 520 | 0.070 |
Why?
| Datasets as Topic | 2 | 2018 | 99 | 0.070 |
Why?
| Wheat Hypersensitivity | 1 | 2006 | 4 | 0.070 |
Why?
| Drug Utilization | 2 | 2017 | 167 | 0.070 |
Why?
| Contraceptives, Oral, Hormonal | 1 | 2006 | 23 | 0.070 |
Why?
| Antibody Specificity | 4 | 2011 | 176 | 0.070 |
Why?
| Hydrogen-Ion Concentration | 2 | 2018 | 511 | 0.070 |
Why?
| Apolipoprotein C-III | 1 | 2006 | 13 | 0.070 |
Why?
| Metagenomics | 2 | 2019 | 131 | 0.070 |
Why?
| Carrier State | 1 | 2006 | 54 | 0.070 |
Why?
| Neoplasm Proteins | 2 | 2020 | 384 | 0.070 |
Why?
| Birth Order | 2 | 2004 | 12 | 0.070 |
Why?
| Adenovirus Infections, Human | 1 | 2005 | 12 | 0.060 |
Why?
| Chronic Disease | 4 | 2017 | 1578 | 0.060 |
Why?
| Paired Box Transcription Factors | 1 | 2005 | 36 | 0.060 |
Why?
| Adenoviruses, Human | 1 | 2005 | 24 | 0.060 |
Why?
| Chromatography, Liquid | 3 | 2012 | 347 | 0.060 |
Why?
| Disease Models, Animal | 2 | 2018 | 3531 | 0.060 |
Why?
| Receptors, Interleukin-4 | 1 | 2005 | 15 | 0.060 |
Why?
| Statistics, Nonparametric | 2 | 2011 | 385 | 0.060 |
Why?
| Codon, Terminator | 1 | 2005 | 21 | 0.060 |
Why?
| Amino Acid Substitution | 1 | 2006 | 262 | 0.060 |
Why?
| Antigens, Differentiation | 1 | 2005 | 79 | 0.060 |
Why?
| Capsid Proteins | 1 | 2005 | 69 | 0.060 |
Why?
| Codon, Nonsense | 1 | 2005 | 37 | 0.060 |
Why?
| Transcriptome | 2 | 2023 | 725 | 0.060 |
Why?
| Protective Factors | 2 | 2015 | 87 | 0.060 |
Why?
| Registries | 7 | 2019 | 1767 | 0.060 |
Why?
| Research Design | 3 | 2019 | 928 | 0.060 |
Why?
| Survivors | 1 | 2008 | 411 | 0.060 |
Why?
| Interleukin-13 | 1 | 2005 | 122 | 0.060 |
Why?
| T-Lymphocytes | 2 | 2023 | 1737 | 0.060 |
Why?
| Fathers | 1 | 2005 | 45 | 0.060 |
Why?
| Radiography, Abdominal | 1 | 2004 | 32 | 0.060 |
Why?
| Nutritional Status | 1 | 2007 | 287 | 0.060 |
Why?
| Arthritis, Juvenile | 1 | 2005 | 42 | 0.060 |
Why?
| RNA, Ribosomal, 16S | 2 | 2018 | 485 | 0.060 |
Why?
| Norway | 2 | 2019 | 36 | 0.060 |
Why?
| Postmenopause | 3 | 2020 | 303 | 0.060 |
Why?
| Pennsylvania | 2 | 2018 | 94 | 0.060 |
Why?
| Cattle | 3 | 2017 | 921 | 0.060 |
Why?
| Anthropometry | 1 | 2004 | 182 | 0.060 |
Why?
| Waist Circumference | 2 | 2015 | 122 | 0.060 |
Why?
| DNA | 2 | 2011 | 1352 | 0.060 |
Why?
| Insulin, Isophane | 1 | 2003 | 17 | 0.060 |
Why?
| Biomedical Research | 1 | 2009 | 585 | 0.060 |
Why?
| Cross-Cultural Comparison | 2 | 2015 | 77 | 0.060 |
Why?
| Confidence Intervals | 1 | 2004 | 305 | 0.050 |
Why?
| International Cooperation | 3 | 2016 | 171 | 0.050 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2022 | 309 | 0.050 |
Why?
| Mice, Knockout | 1 | 2009 | 2568 | 0.050 |
Why?
| Iron, Dietary | 1 | 2023 | 19 | 0.050 |
Why?
| Creatine | 1 | 2023 | 50 | 0.050 |
Why?
| Aspartic Acid | 1 | 2023 | 77 | 0.050 |
Why?
| Peptides, Cyclic | 1 | 2005 | 253 | 0.050 |
Why?
| Glycomics | 1 | 2022 | 7 | 0.050 |
Why?
| Renal Dialysis | 1 | 2006 | 374 | 0.050 |
Why?
| Markov Chains | 2 | 2020 | 114 | 0.050 |
Why?
| Observational Studies as Topic | 1 | 2023 | 90 | 0.050 |
Why?
| Electrocardiography | 2 | 2010 | 560 | 0.050 |
Why?
| HLA-DQ alpha-Chains | 2 | 2019 | 14 | 0.050 |
Why?
| Choline | 1 | 2023 | 106 | 0.050 |
Why?
| Candida | 1 | 2022 | 32 | 0.050 |
Why?
| Multicenter Studies as Topic | 1 | 2023 | 249 | 0.050 |
Why?
| Homeodomain Proteins | 1 | 2005 | 463 | 0.050 |
Why?
| HLA-B15 Antigen | 2 | 2012 | 13 | 0.050 |
Why?
| Insulins | 1 | 2022 | 32 | 0.050 |
Why?
| Prenatal Care | 1 | 2004 | 253 | 0.050 |
Why?
| Electrochemistry | 1 | 2021 | 79 | 0.050 |
Why?
| Epitopes, B-Lymphocyte | 1 | 2021 | 16 | 0.050 |
Why?
| CpG Islands | 1 | 2021 | 117 | 0.050 |
Why?
| China | 1 | 2021 | 161 | 0.050 |
Why?
| Perception | 1 | 2023 | 311 | 0.050 |
Why?
| Fungi | 1 | 2022 | 124 | 0.050 |
Why?
| Linoleic Acid | 1 | 2021 | 37 | 0.050 |
Why?
| Diagnostic Techniques, Radioisotope | 1 | 2021 | 8 | 0.050 |
Why?
| Immunoglobulin D | 1 | 2021 | 27 | 0.050 |
Why?
| Serologic Tests | 1 | 2021 | 49 | 0.050 |
Why?
| Pregnancy Trimester, Third | 1 | 2021 | 79 | 0.050 |
Why?
| p-Aminohippuric Acid | 1 | 2020 | 6 | 0.050 |
Why?
| Depression | 1 | 2009 | 1134 | 0.040 |
Why?
| Protein Interaction Mapping | 1 | 2021 | 101 | 0.040 |
Why?
| Benchmarking | 1 | 2022 | 161 | 0.040 |
Why?
| Kidney Transplantation | 1 | 2006 | 541 | 0.040 |
Why?
| Models, Statistical | 3 | 2015 | 599 | 0.040 |
Why?
| Iohexol | 1 | 2020 | 16 | 0.040 |
Why?
| Furosemide | 1 | 2020 | 32 | 0.040 |
Why?
| Viral Proteins | 2 | 2006 | 281 | 0.040 |
Why?
| Isotopes | 1 | 2020 | 27 | 0.040 |
Why?
| Drug Discovery | 1 | 2021 | 123 | 0.040 |
Why?
| Drug Administration Schedule | 2 | 2017 | 718 | 0.040 |
Why?
| Dehydroascorbic Acid | 1 | 2020 | 1 | 0.040 |
Why?
| Whole Genome Sequencing | 1 | 2020 | 94 | 0.040 |
Why?
| Algorithms | 2 | 2018 | 1467 | 0.040 |
Why?
| Gastrointestinal Tract | 1 | 2022 | 169 | 0.040 |
Why?
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 92 | 0.040 |
Why?
| Amino Acids, Branched-Chain | 1 | 2020 | 31 | 0.040 |
Why?
| Growth Charts | 1 | 2020 | 14 | 0.040 |
Why?
| Peroxidase | 1 | 2020 | 163 | 0.040 |
Why?
| Glucose Transporter Type 2 | 1 | 2019 | 10 | 0.040 |
Why?
| Antibody Diversity | 1 | 2019 | 16 | 0.040 |
Why?
| Antibodies, Heterophile | 1 | 1999 | 13 | 0.040 |
Why?
| Haemophilus influenzae type b | 1 | 1999 | 10 | 0.040 |
Why?
| Phosphatidylethanolamines | 1 | 2020 | 66 | 0.040 |
Why?
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1999 | 25 | 0.040 |
Why?
| Salaries and Fringe Benefits | 1 | 2020 | 52 | 0.040 |
Why?
| Alanine | 1 | 2020 | 104 | 0.040 |
Why?
| Poliovirus Vaccine, Inactivated | 1 | 1999 | 22 | 0.040 |
Why?
| Measles-Mumps-Rubella Vaccine | 1 | 2019 | 41 | 0.040 |
Why?
| Haemophilus Vaccines | 1 | 1999 | 27 | 0.040 |
Why?
| Femur Neck | 1 | 2020 | 59 | 0.040 |
Why?
| Proline | 1 | 2020 | 72 | 0.040 |
Why?
| Immunoglobulin M | 1 | 2021 | 246 | 0.040 |
Why?
| Texas | 2 | 2014 | 188 | 0.040 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2021 | 470 | 0.040 |
Why?
| Gene Regulatory Networks | 1 | 2021 | 228 | 0.040 |
Why?
| Efficiency | 1 | 2020 | 84 | 0.040 |
Why?
| Hepatitis B Vaccines | 1 | 1999 | 46 | 0.040 |
Why?
| Macaca mulatta | 1 | 2019 | 131 | 0.040 |
Why?
| Bayes Theorem | 1 | 2021 | 329 | 0.040 |
Why?
| Chromatography, Reverse-Phase | 1 | 2019 | 26 | 0.040 |
Why?
| Immunoglobulin E | 1 | 2021 | 314 | 0.040 |
Why?
| Methionine | 1 | 2020 | 144 | 0.040 |
Why?
| Pediatricians | 1 | 2020 | 122 | 0.040 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 2019 | 124 | 0.040 |
Why?
| Maternal Behavior | 1 | 1999 | 70 | 0.040 |
Why?
| Alternative Splicing | 1 | 2000 | 187 | 0.040 |
Why?
| gamma-Aminobutyric Acid | 1 | 2020 | 144 | 0.040 |
Why?
| Adenoviridae | 1 | 2019 | 184 | 0.040 |
Why?
| Receptor, Insulin | 1 | 1999 | 93 | 0.040 |
Why?
| Phosphoproteins | 1 | 2021 | 298 | 0.040 |
Why?
| Proteobacteria | 1 | 2018 | 16 | 0.040 |
Why?
| beta 2-Microglobulin | 1 | 2018 | 45 | 0.040 |
Why?
| Firmicutes | 1 | 2018 | 17 | 0.040 |
Why?
| Feasibility Studies | 2 | 2015 | 740 | 0.040 |
Why?
| Lipocalin-2 | 1 | 2018 | 61 | 0.040 |
Why?
| Pets | 1 | 2018 | 20 | 0.040 |
Why?
| Down-Regulation | 1 | 2021 | 594 | 0.040 |
Why?
| Employment | 1 | 2020 | 137 | 0.040 |
Why?
| Fatty Acids, Volatile | 1 | 2018 | 47 | 0.040 |
Why?
| Severity of Illness Index | 2 | 2016 | 2537 | 0.040 |
Why?
| Molecular Targeted Therapy | 1 | 2021 | 347 | 0.040 |
Why?
| Postpartum Period | 1 | 2021 | 278 | 0.040 |
Why?
| Emotional Adjustment | 1 | 2018 | 17 | 0.040 |
Why?
| Microscopy, Polarization | 1 | 2018 | 30 | 0.040 |
Why?
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2018 | 35 | 0.040 |
Why?
| Interleukins | 1 | 2020 | 236 | 0.040 |
Why?
| Lumbar Vertebrae | 1 | 2020 | 209 | 0.040 |
Why?
| Quantitative Trait Loci | 1 | 2020 | 305 | 0.040 |
Why?
| Apolipoprotein A-I | 1 | 1997 | 25 | 0.040 |
Why?
| Osmolar Concentration | 1 | 2018 | 173 | 0.040 |
Why?
| Loss of Function Mutation | 1 | 2017 | 36 | 0.040 |
Why?
| Estrogen Replacement Therapy | 1 | 1998 | 116 | 0.040 |
Why?
| Collagen | 1 | 2020 | 415 | 0.040 |
Why?
| Canada | 1 | 2018 | 322 | 0.040 |
Why?
| Longevity | 1 | 2018 | 137 | 0.040 |
Why?
| Discriminant Analysis | 1 | 2017 | 37 | 0.040 |
Why?
| Pelvic Bones | 1 | 2020 | 126 | 0.040 |
Why?
| Lipoprotein(a) | 1 | 1997 | 51 | 0.040 |
Why?
| United Kingdom | 1 | 2018 | 226 | 0.040 |
Why?
| Anxiety | 1 | 2023 | 840 | 0.040 |
Why?
| Bicarbonates | 1 | 2017 | 41 | 0.040 |
Why?
| Vascular Resistance | 1 | 2018 | 337 | 0.040 |
Why?
| Vitamin E | 1 | 1997 | 110 | 0.040 |
Why?
| Receptor, ErbB-3 | 1 | 2017 | 41 | 0.040 |
Why?
| Biopsy, Needle | 2 | 2011 | 182 | 0.040 |
Why?
| Galactosamine | 1 | 2016 | 3 | 0.040 |
Why?
| Cluster Analysis | 1 | 2018 | 455 | 0.040 |
Why?
| Acetylglucosamine | 1 | 2016 | 10 | 0.030 |
Why?
| Random Allocation | 1 | 2018 | 335 | 0.030 |
Why?
| Molecular Weight | 2 | 2012 | 331 | 0.030 |
Why?
| Disease Management | 1 | 2020 | 560 | 0.030 |
Why?
| Regional Blood Flow | 1 | 2018 | 424 | 0.030 |
Why?
| Anemia, Sickle Cell | 1 | 2000 | 215 | 0.030 |
Why?
| Africa | 2 | 1996 | 94 | 0.030 |
Why?
| Endpoint Determination | 1 | 2017 | 68 | 0.030 |
Why?
| Protein Domains | 1 | 2017 | 207 | 0.030 |
Why?
| Rotavirus Vaccines | 1 | 2016 | 48 | 0.030 |
Why?
| Bacteria | 1 | 2022 | 725 | 0.030 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 139 | 0.030 |
Why?
| Antibody Affinity | 1 | 2016 | 52 | 0.030 |
Why?
| Vitreoretinopathy, Proliferative | 1 | 2016 | 10 | 0.030 |
Why?
| Membrane Glycoproteins | 1 | 1998 | 430 | 0.030 |
Why?
| Genetic Background | 1 | 2015 | 8 | 0.030 |
Why?
| Organ Specificity | 2 | 2007 | 268 | 0.030 |
Why?
| Disease-Free Survival | 1 | 2017 | 620 | 0.030 |
Why?
| Mice, Inbred BALB C | 2 | 2013 | 1143 | 0.030 |
Why?
| Interleukin-2 Receptor alpha Subunit | 1 | 2015 | 66 | 0.030 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 520 | 0.030 |
Why?
| Hospitalization | 1 | 2004 | 1750 | 0.030 |
Why?
| HEK293 Cells | 1 | 2017 | 591 | 0.030 |
Why?
| Georgia | 1 | 2015 | 62 | 0.030 |
Why?
| Florida | 1 | 2015 | 73 | 0.030 |
Why?
| Heterozygote | 1 | 2016 | 251 | 0.030 |
Why?
| Analysis of Variance | 3 | 2010 | 1226 | 0.030 |
Why?
| Smoking Cessation | 1 | 2019 | 374 | 0.030 |
Why?
| Thyroglobulin | 2 | 2005 | 17 | 0.030 |
Why?
| DNA Primers | 1 | 1996 | 510 | 0.030 |
Why?
| Genes | 1 | 1995 | 223 | 0.030 |
Why?
| Radioligand Assay | 2 | 2009 | 43 | 0.030 |
Why?
| Washington | 1 | 2015 | 134 | 0.030 |
Why?
| Solubility | 1 | 2015 | 223 | 0.030 |
Why?
| Area Under Curve | 1 | 2015 | 274 | 0.030 |
Why?
| Blood Pressure Determination | 1 | 2015 | 122 | 0.030 |
Why?
| Insulin, Long-Acting | 2 | 2005 | 52 | 0.030 |
Why?
| Sequence Homology, Amino Acid | 1 | 2015 | 353 | 0.030 |
Why?
| International Classification of Diseases | 1 | 2015 | 116 | 0.030 |
Why?
| Insulin Glargine | 2 | 2005 | 73 | 0.030 |
Why?
| Tunica Intima | 3 | 2000 | 78 | 0.030 |
Why?
| Achievement | 1 | 2014 | 54 | 0.030 |
Why?
| Seasons | 4 | 1992 | 442 | 0.030 |
Why?
| Family Characteristics | 1 | 2015 | 151 | 0.030 |
Why?
| Retrospective Studies | 3 | 2014 | 12544 | 0.030 |
Why?
| Epidemiologic Factors | 1 | 2013 | 8 | 0.030 |
Why?
| Plaque, Atherosclerotic | 1 | 2014 | 44 | 0.030 |
Why?
| Antigen-Antibody Reactions | 1 | 2013 | 50 | 0.030 |
Why?
| Aging | 3 | 2000 | 1618 | 0.030 |
Why?
| Base Sequence | 2 | 2011 | 2114 | 0.030 |
Why?
| Complement C1 Inactivator Proteins | 1 | 2012 | 6 | 0.030 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 1998 | 687 | 0.030 |
Why?
| Complement C1 Inhibitor Protein | 1 | 2012 | 7 | 0.030 |
Why?
| California | 2 | 2004 | 353 | 0.030 |
Why?
| Niacinamide | 1 | 1993 | 63 | 0.030 |
Why?
| Interleukin-10 | 1 | 2015 | 299 | 0.030 |
Why?
| Albumins | 1 | 2013 | 89 | 0.030 |
Why?
| Comorbidity | 1 | 2017 | 1448 | 0.030 |
Why?
| S100 Calcium Binding Protein beta Subunit | 1 | 2012 | 8 | 0.030 |
Why?
| Biometry | 1 | 1993 | 62 | 0.030 |
Why?
| Residence Characteristics | 1 | 2014 | 275 | 0.030 |
Why?
| Vaccines, Inactivated | 1 | 2012 | 68 | 0.030 |
Why?
| Nitrates | 1 | 1992 | 72 | 0.030 |
Why?
| S100 Proteins | 1 | 2012 | 38 | 0.030 |
Why?
| Phylogeny | 2 | 2006 | 789 | 0.030 |
Why?
| Genome | 1 | 2014 | 271 | 0.030 |
Why?
| Nerve Growth Factors | 1 | 2012 | 71 | 0.030 |
Why?
| Water Supply | 1 | 1992 | 70 | 0.030 |
Why?
| Luciferases | 1 | 2012 | 142 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2012 | 151 | 0.030 |
Why?
| Potassium Channels | 1 | 2012 | 121 | 0.020 |
Why?
| Diagnostic Techniques, Endocrine | 1 | 2011 | 14 | 0.020 |
Why?
| Societies, Medical | 1 | 2015 | 663 | 0.020 |
Why?
| 25-Hydroxyvitamin D 2 | 1 | 2011 | 7 | 0.020 |
Why?
| Observation | 1 | 2011 | 50 | 0.020 |
Why?
| Brain | 1 | 2023 | 2371 | 0.020 |
Why?
| Adenosine Triphosphatases | 1 | 2012 | 153 | 0.020 |
Why?
| Abdominal Fat | 1 | 2012 | 39 | 0.020 |
Why?
| Diagnosis, Differential | 2 | 2011 | 1342 | 0.020 |
Why?
| Ubiquitins | 1 | 2011 | 31 | 0.020 |
Why?
| Insulinoma | 1 | 2011 | 29 | 0.020 |
Why?
| Iodine Radioisotopes | 1 | 2011 | 125 | 0.020 |
Why?
| Causality | 1 | 1991 | 103 | 0.020 |
Why?
| Leptin | 1 | 2012 | 210 | 0.020 |
Why?
| Dietary Fats, Unsaturated | 1 | 2011 | 21 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 318 | 0.020 |
Why?
| Peptide Fragments | 2 | 2007 | 666 | 0.020 |
Why?
| Aged, 80 and over | 2 | 2018 | 6345 | 0.020 |
Why?
| Endothelium, Vascular | 2 | 2008 | 847 | 0.020 |
Why?
| Observer Variation | 1 | 2011 | 295 | 0.020 |
Why?
| DNA Replication | 1 | 2011 | 202 | 0.020 |
Why?
| Radioimmunoprecipitation Assay | 1 | 2009 | 6 | 0.020 |
Why?
| Staphylococcal Protein A | 1 | 2009 | 9 | 0.020 |
Why?
| Microchemistry | 1 | 2009 | 15 | 0.020 |
Why?
| Biostatistics | 1 | 2009 | 15 | 0.020 |
Why?
| Cholera Toxin | 1 | 2009 | 27 | 0.020 |
Why?
| Inflammation Mediators | 1 | 2012 | 477 | 0.020 |
Why?
| Graves Disease | 1 | 2009 | 32 | 0.020 |
Why?
| Intra-Abdominal Fat | 1 | 2010 | 77 | 0.020 |
Why?
| Fetal Weight | 1 | 2009 | 52 | 0.020 |
Why?
| Vaccination | 1 | 2017 | 1204 | 0.020 |
Why?
| Calibration | 1 | 2009 | 125 | 0.020 |
Why?
| Survival Rate | 2 | 2006 | 1644 | 0.020 |
Why?
| DNA Mutational Analysis | 1 | 2010 | 372 | 0.020 |
Why?
| Microsatellite Repeats | 1 | 2009 | 136 | 0.020 |
Why?
| Pancreatic Polypeptide | 1 | 1989 | 3 | 0.020 |
Why?
| Intestinal Absorption | 1 | 2009 | 93 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2010 | 493 | 0.020 |
Why?
| Chromosomes, Human, Pair 5 | 1 | 2008 | 24 | 0.020 |
Why?
| Radiography | 1 | 2011 | 812 | 0.020 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2008 | 49 | 0.020 |
Why?
| Interferon-Induced Helicase, IFIH1 | 1 | 2008 | 13 | 0.020 |
Why?
| Outpatients | 1 | 1992 | 326 | 0.020 |
Why?
| Tunica Media | 2 | 2000 | 35 | 0.020 |
Why?
| Protein Precursors | 1 | 2009 | 119 | 0.020 |
Why?
| Glucagon | 1 | 1989 | 92 | 0.020 |
Why?
| Pregnancy in Diabetics | 1 | 2009 | 82 | 0.020 |
Why?
| Personality Inventory | 1 | 2009 | 131 | 0.020 |
Why?
| Telecommunications | 1 | 1988 | 16 | 0.020 |
Why?
| Nutrition Therapy | 1 | 2008 | 31 | 0.020 |
Why?
| Genetic Carrier Screening | 1 | 2008 | 24 | 0.020 |
Why?
| Interferon-alpha | 1 | 2009 | 186 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2000 | 923 | 0.020 |
Why?
| Pacific Islands | 1 | 1988 | 2 | 0.020 |
Why?
| Solanum tuberosum | 1 | 2008 | 7 | 0.020 |
Why?
| Probability | 1 | 1989 | 289 | 0.020 |
Why?
| Diabetic Neuropathies | 1 | 2009 | 79 | 0.020 |
Why?
| Americas | 1 | 1988 | 19 | 0.020 |
Why?
| Asia | 1 | 1988 | 53 | 0.020 |
Why?
| Survival | 1 | 2007 | 37 | 0.020 |
Why?
| Bottle Feeding | 1 | 2007 | 20 | 0.020 |
Why?
| Carotenoids | 1 | 2007 | 35 | 0.020 |
Why?
| Antibodies, Monoclonal | 1 | 2013 | 1262 | 0.020 |
Why?
| Vegetables | 1 | 2008 | 133 | 0.020 |
Why?
| Metabolic Networks and Pathways | 1 | 2008 | 168 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2011 | 1629 | 0.020 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 2006 | 44 | 0.020 |
Why?
| DNA-Directed RNA Polymerases | 1 | 2006 | 51 | 0.020 |
Why?
| 5' Untranslated Regions | 1 | 2006 | 51 | 0.020 |
Why?
| Molecular Epidemiology | 1 | 2006 | 62 | 0.020 |
Why?
| Protein Array Analysis | 1 | 2006 | 56 | 0.020 |
Why?
| RNA, Messenger | 1 | 2013 | 2552 | 0.020 |
Why?
| Self Care | 1 | 2009 | 349 | 0.020 |
Why?
| Serotyping | 1 | 2005 | 28 | 0.020 |
Why?
| Sequence Alignment | 1 | 2006 | 323 | 0.020 |
Why?
| Treatment Outcome | 2 | 2004 | 9087 | 0.020 |
Why?
| Species Specificity | 1 | 2006 | 542 | 0.020 |
Why?
| Ultrasonography | 2 | 2000 | 633 | 0.020 |
Why?
| Alprostadil | 1 | 2005 | 32 | 0.020 |
Why?
| Genome, Viral | 1 | 2005 | 118 | 0.020 |
Why?
| National Institutes of Health (U.S.) | 1 | 2005 | 106 | 0.020 |
Why?
| Polyethylene Glycols | 1 | 2009 | 561 | 0.010 |
Why?
| Data Interpretation, Statistical | 1 | 2006 | 321 | 0.010 |
Why?
| Mutation | 1 | 2015 | 3345 | 0.010 |
Why?
| Puerto Rico | 1 | 2004 | 51 | 0.010 |
Why?
| Dinoprostone | 1 | 2005 | 184 | 0.010 |
Why?
| False Positive Reactions | 1 | 2004 | 109 | 0.010 |
Why?
| Regeneration | 1 | 2005 | 160 | 0.010 |
Why?
| Embryonic and Fetal Development | 1 | 2003 | 94 | 0.010 |
Why?
| DNA, Viral | 1 | 2005 | 350 | 0.010 |
Why?
| Single-Blind Method | 1 | 2004 | 258 | 0.010 |
Why?
| Insulin Lispro | 1 | 2003 | 35 | 0.010 |
Why?
| Mice, Transgenic | 1 | 2008 | 1947 | 0.010 |
Why?
| Guidelines as Topic | 1 | 2005 | 243 | 0.010 |
Why?
| Duodenum | 1 | 2003 | 62 | 0.010 |
Why?
| Health | 1 | 2003 | 74 | 0.010 |
Why?
| Income | 1 | 2003 | 167 | 0.010 |
Why?
| HLA-A Antigens | 1 | 2002 | 49 | 0.010 |
Why?
| Circadian Rhythm | 1 | 1985 | 354 | 0.010 |
Why?
| Models, Immunological | 1 | 2002 | 92 | 0.010 |
Why?
| Mental Recall | 1 | 2003 | 171 | 0.010 |
Why?
| Cells, Cultured | 1 | 2008 | 3885 | 0.010 |
Why?
| Blotting, Southern | 1 | 2000 | 68 | 0.010 |
Why?
| Carotid Artery, Internal | 1 | 2000 | 36 | 0.010 |
Why?
| Carotid Artery, Common | 1 | 2000 | 29 | 0.010 |
Why?
| DNA, Complementary | 1 | 2000 | 256 | 0.010 |
Why?
| Signal Transduction | 1 | 2012 | 4512 | 0.010 |
Why?
| Acute Disease | 1 | 2002 | 910 | 0.010 |
Why?
| Cholesterol, VLDL | 1 | 1999 | 4 | 0.010 |
Why?
| Genetic Counseling | 1 | 1999 | 65 | 0.010 |
Why?
| Twins, Dizygotic | 1 | 1999 | 182 | 0.010 |
Why?
| Epitope Mapping | 1 | 1998 | 51 | 0.010 |
Why?
| Lymphocyte Count | 1 | 1998 | 133 | 0.010 |
Why?
| Arthritis, Rheumatoid | 1 | 2006 | 1003 | 0.010 |
Why?
| Twins, Monozygotic | 1 | 1999 | 210 | 0.010 |
Why?
| CD4 Lymphocyte Count | 1 | 1998 | 257 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 2006 | 2319 | 0.010 |
Why?
| Demography | 1 | 1998 | 260 | 0.010 |
Why?
| Cholesterol, LDL | 1 | 1998 | 307 | 0.010 |
Why?
| Quantitative Trait, Heritable | 1 | 1997 | 116 | 0.010 |
Why?
| Bacterial Infections | 1 | 1998 | 218 | 0.010 |
Why?
| Mexico | 1 | 1996 | 162 | 0.010 |
Why?
| T-Lymphocyte Subsets | 1 | 1998 | 383 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2000 | 2218 | 0.010 |
Why?
| Quality of Life | 1 | 2005 | 2353 | 0.010 |
Why?
| Mental Disorders | 1 | 2002 | 892 | 0.010 |
Why?
| Energy Metabolism | 1 | 1998 | 731 | 0.010 |
Why?
| Software | 1 | 1997 | 530 | 0.010 |
Why?
| Computer Simulation | 1 | 1997 | 872 | 0.010 |
Why?
| Baltic States | 1 | 1992 | 1 | 0.010 |
Why?
| Rats | 1 | 2000 | 4958 | 0.010 |
Why?
| Geography | 1 | 1992 | 177 | 0.010 |
Why?
| Cohort Effect | 1 | 1990 | 3 | 0.010 |
Why?
| Periodicity | 1 | 1990 | 55 | 0.010 |
Why?
| Space-Time Clustering | 1 | 1989 | 3 | 0.010 |
Why?
| Actuarial Analysis | 1 | 1989 | 21 | 0.010 |
Why?
| Coxsackievirus Infections | 1 | 1987 | 12 | 0.000 |
Why?
| Rubella | 1 | 1987 | 21 | 0.000 |
Why?
| Mortality | 1 | 1989 | 287 | 0.000 |
Why?
| Cause of Death | 1 | 1989 | 361 | 0.000 |
Why?
| Neoplasms | 1 | 1989 | 2097 | 0.000 |
Why?
|
|
Rewers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|